Search results for: Pricing and Reimbursement
Filter search results
Around the World in HTAs: Canada – Autonomous yet Collaborative
9 April 2025
…by the Canada Health Act. Each province and territory has its own prescription medicines plan, and eligibility and formularies can differ dramatically. The provinces and territories guard their independence –…
Mikel Berdud
26 February 2015
…investment; the implications of value-based pricing and other innovative pricing approaches in incentivising innovation and maximising social welfare; the role of competition (on- and off-patent) on promoting access to, and…
Analysing Global Immunisation Expenditure
15 April 2025
…(such as COVID-19, pneumococcal and herpes zoster) and adolescent programmes (such as meningococcal). Data gaps hinder effective policy-making and monitoring Data on immunisation spending by age group and programme is…
Changes in Determining Medicines Pricing in France, Germany and the UK
24 January 2013
…being discussed in pricing and reimbursement/HTA systems in France, Germany and the UK. New requirements for health technology assessment in Europe have important implications for markets and for access to…
Europe’s pharmaceutical policy choices – And what the United States stands to learn
18 March 2026
…choices that reflect different social preferences, institutional structures, and political constraints. These choices are deliberate — and they involve the kind of trade-offs Dan presented to the audience of US politicians and staffers. Understanding…
The Dynamics of Drug Shortages
9 January 2024
…price change of other products with the same molecule, iii) market concentration, iv) demand and competition, and v) patent expiration), which can be used to determine shortages’ factors and value…
Spotlight on OHE: Measuring Preferences, HTA Benchmarking, Value-Based Pricing, and Rationing
13 October 2011
…methods and processes, and the economics of the pharmaceutical and life sciences industries. This post briefly reviews OHE’s September 2011 activities that contribute to advancing thought and stimulating innovative ideas…
A Market-based International Reference Price Index: Solution or Contradiction?
13 September 2019
…reference-pricing framework Analogously, there are between-country differences with respect to the adoption of a therapeutic reference-based pricing framework. Therapeutic reference pricing schemes are used in the Netherlands, Switzerland, and Denmark,…
New Research: Achieving Efficient Prices for Drugs in a Global Context
7 February 2013
…in countries with universal insurance may approximate a value-based differential pricing model if willingness to pay is used appropriately in setting a cost-effectiveness threshold for pricing and reimbursement decisions. If…